Apimeds Pharmaceuticals US, Inc.

APUS · NYSE · SIC 2834: Pharmaceutical Preparations · 2 employees
37
SEC Filings
$2.92
Close 2026-11-04
2
Employees

Business Summary

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company developing Apitox, an intradermally administered, purified bee venom-based toxin derived from the western honeybee. The company focuses on treating inflammation and pain management symptoms associated with knee osteoarthritis (OA) and, secondarily, multiple sclerosis (MS). Apitox is not yet FDA-approved. A related product, Apitoxin, is marketed in South Korea by Apimeds Korea and approved by the Korean MFDA since 2003.

Latest Stock Quote

APUS 2026-11-04 $2.92 O:$2.98 H:$2.98 L:$2.68 Vol:0.0M VWAP:$2.8352
origin leaf: null

Next Earnings

expected 2026-11-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-152024-12-310001213900-25-032206EDGAR45K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001213900-26-090120EDGAR20K words
2025-11-122025-09-300001213900-25-109280EDGAR18K words
2025-08-192025-06-300001213900-25-078507EDGAR18K words
2025-05-202025-03-310001213900-25-045588EDGAR13K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-130001213900-26-108780EDGAR1K words
2026-10-010001213900-26-105484EDGAR1K words
2026-09-290001213900-26-104668EDGAR1K words
2026-09-230001213900-26-102321EDGAR1K words
2026-09-110001213900-26-099002EDGAR1K words
2026-08-210001213900-26-092680EDGAR1K words
2026-08-060001213900-26-086244EDGAR1K words
2026-07-130001213900-26-077591EDGAR1K words
2026-03-260001213900-26-034786EDGAR2K words
2026-03-250001213900-26-033832EDGAR3K words

37 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

osteoarthritis-therapeutics multiple-sclerosis-therapeutics inflammation-and-pain-management

Company Identity

CIK0001894525
TickerAPUS
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.apimedsus.com
Listed2025-05-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ad8b0f02e91c1c06ed7c35025e275caaa230fa25a4de1d8b14804eadc77a84a8
parent: 25b97bc011879b1c8c75adddb0cf4d16f9923593a142477aae695808aa180aa5
content hash: 4ce4c2ba984e06f91d29eefabba66d739215ef328ee51c858567ff5e5e2e0bdf
signed: 2026-11-16T19:00:40.107Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APUS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APUS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APUS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.